Designing a medical device is one of the most demanding challenges in product development. Unlike consumer products, the stakes are literal: poorly designed devices contribute to thousands of use errors and patient injuries every year. The FDA estimates that use errors—most of which are attributable to device design rather than user negligence—are a leading cause of adverse events in clinical settings.
510(k) Clearance: For Class II devices (moderate risk). Requires demonstration that your device is substantially equivalent to a legally marketed predicate. Typically takes 6–12 months.
PMA (Premarket Approval): For Class III devices (high risk). Requires clinical evidence of safety and effectiveness. Typically requires 12–36 months and significantly more data.
De Novo Classification: For novel low-to-moderate risk devices without a suitable predicate. Increasingly important as new device categories emerge.
FDA clearance or approval is not the end of the design process. Under 21 CFR Part 820, you’re required to monitor device performance in the field and use post-market data to continuously improve your device. Building surveillance capability into your quality system before launch is essential for sustainable compliance. To learn more about how RKS Design approaches medical device design, visit our medical device design page.
Welcome to a world of design and innovation
If this is not the case, then click the button below to start it